Financials Englewood Lab, Inc.

Equities

A950140

KR8840110108

Personal Products

End-of-day quote Korea S.E. 18:00:00 2024-05-13 EDT 5-day change 1st Jan Change
15,900 KRW -0.44% Intraday chart for Englewood Lab, Inc. +5.65% +19.28%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 123,777 87,816 99,141 170,864 101,127 264,839
Enterprise Value (EV) 1 149,859 113,826 111,906 189,873 115,151 259,973
P/E ratio -21 x 38.7 x 32.2 x 11.4 x 13.9 x 12.8 x
Yield - - - - - 0.75%
Capitalization / Revenue 1.04 x 0.66 x 0.72 x 1.06 x 0.67 x 1.28 x
EV / Revenue 1.26 x 0.85 x 0.82 x 1.18 x 0.76 x 1.26 x
EV / EBITDA 54 x 10.1 x 9.09 x 8.95 x 8.09 x 7.82 x
EV / FCF -6.49 x 13.3 x 24.2 x -11.3 x 493 x 16.7 x
FCF Yield -15.4% 7.54% 4.13% -8.85% 0.2% 6%
Price to Book 0.16 x 1.44 x 1.63 x 2.11 x 1.09 x 2.3 x
Nbr of stocks (in thousands) 19,868 19,868 19,868 19,868 19,868 19,868
Reference price 2 6,230 4,420 4,990 8,600 5,090 13,330
Announcement Date 19-03-21 20-03-02 21-03-17 22-03-16 23-03-15 24-03-21
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 118,766 133,317 137,168 160,816 151,509 206,784
EBITDA 1 2,773 11,286 12,307 21,209 14,230 33,249
EBIT 1 -278.8 6,746 7,869 16,905 9,882 28,855
Operating Margin -0.23% 5.06% 5.74% 10.51% 6.52% 13.95%
Earnings before Tax (EBT) 1 -4,819 5,641 4,801 15,098 8,353 28,715
Net income 1 -5,899 2,269 3,082 14,997 7,265 20,742
Net margin -4.97% 1.7% 2.25% 9.33% 4.8% 10.03%
EPS 2 -297.0 114.2 155.1 754.9 365.7 1,044
Free Cash Flow 1 -23,076 8,587 4,619 -16,796 233.5 15,592
FCF margin -19.43% 6.44% 3.37% -10.44% 0.15% 7.54%
FCF Conversion (EBITDA) - 76.09% 37.53% - 1.64% 46.89%
FCF Conversion (Net income) - 378.54% 149.87% - 3.21% 75.17%
Dividend per Share - - - - - 100.0
Announcement Date 19-03-21 20-03-02 21-03-17 22-03-16 23-03-15 24-03-21
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 26,083 26,010 12,766 19,010 14,023 -
Net Cash position 1 - - - - - 4,865
Leverage (Debt/EBITDA) 9.405 x 2.305 x 1.037 x 0.8963 x 0.9855 x -
Free Cash Flow 1 -23,076 8,587 4,619 -16,796 233 15,592
ROE (net income / shareholders' equity) -10.1% 3.85% 5.06% 21.2% 8.35% 20%
ROA (Net income/ Total Assets) -0.18% 3.83% 4.39% 8.92% 4.69% 11.7%
Assets 1 3,338,339 59,215 70,200 168,131 155,025 177,708
Book Value Per Share 2 38,270 3,077 3,053 4,074 4,682 5,784
Cash Flow per Share 2 746.0 275.0 518.0 448.0 560.0 576.0
Capex 1 13,207 4,897 3,977 2,368 4,099 2,580
Capex / Sales 11.12% 3.67% 2.9% 1.47% 2.71% 1.25%
Announcement Date 19-03-21 20-03-02 21-03-17 22-03-16 23-03-15 24-03-21
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A950140 Stock
  4. Financials Englewood Lab, Inc.
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**BENEFIT NOW**0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW